437 related articles for article (PubMed ID: 31243313)
1. Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study.
Brüggemann M; Kotrová M; Knecht H; Bartram J; Boudjogrha M; Bystry V; Fazio G; Froňková E; Giraud M; Grioni A; Hancock J; Herrmann D; Jiménez C; Krejci A; Moppett J; Reigl T; Salson M; Scheijen B; Schwarz M; Songia S; Svaton M; van Dongen JJM; Villarese P; Wakeman S; Wright G; Cazzaniga G; Davi F; García-Sanz R; Gonzalez D; Groenen PJTA; Hummel M; Macintyre EA; Stamatopoulos K; Pott C; Trka J; Darzentas N; Langerak AW;
Leukemia; 2019 Sep; 33(9):2241-2253. PubMed ID: 31243313
[TBL] [Abstract][Full Text] [Related]
2. Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS.
Knecht H; Reigl T; Kotrová M; Appelt F; Stewart P; Bystry V; Krejci A; Grioni A; Pal K; Stranska K; Plevova K; Rijntjes J; Songia S; Svatoň M; Froňková E; Bartram J; Scheijen B; Herrmann D; García-Sanz R; Hancock J; Moppett J; van Dongen JJM; Cazzaniga G; Davi F; Groenen PJTA; Hummel M; Macintyre EA; Stamatopoulos K; Trka J; Langerak AW; Gonzalez D; Pott C; Brüggemann M; Darzentas N;
Leukemia; 2019 Sep; 33(9):2254-2265. PubMed ID: 31227779
[TBL] [Abstract][Full Text] [Related]
3. One-Step Next-Generation Sequencing of Immunoglobulin and T-Cell Receptor Gene Recombinations for MRD Marker Identification in Acute Lymphoblastic Leukemia.
Villarese P; Abdo C; Bertrand M; Thonier F; Giraud M; Salson M; Macintyre E
Methods Mol Biol; 2022; 2453():43-59. PubMed ID: 35622319
[TBL] [Abstract][Full Text] [Related]
4. Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?
Kotrova M; Trka J; Kneba M; Brüggemann M
Mol Diagn Ther; 2017 Oct; 21(5):481-492. PubMed ID: 28452038
[TBL] [Abstract][Full Text] [Related]
5. [Identification of immunoglobulin and T-cell receptor gene rearrangements--prerequisite for monitoring of minimal residual disease in Polish acute lymphoblastic leukemia patients based on European standards. Preliminary results].
Dawidowska M; Derwich K; Szczepański T; Jółkowska J; Witt M; Wachowiak J
Med Wieku Rozwoj; 2006; 10(1 Pt 2):323-34. PubMed ID: 17028396
[TBL] [Abstract][Full Text] [Related]
6. Next-Generation Sequencing Technology to Identify Minimal Residual Disease in Lymphoid Malignancies.
Kotrova M; Darzentas N; Pott C; Brüggemann M;
Methods Mol Biol; 2021; 2185():95-111. PubMed ID: 33165845
[TBL] [Abstract][Full Text] [Related]
7. NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol.
Svaton M; Skotnicova A; Reznickova L; Rennerova A; Valova T; Kotrova M; van der Velden VHJ; Brüggemann M; Darzentas N; Langerak AW; Zuna J; Stary J; Trka J; Fronkova E
Blood; 2023 Feb; 141(5):529-533. PubMed ID: 36240445
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS.
Scheijen B; Meijers RWJ; Rijntjes J; van der Klift MY; Möbs M; Steinhilber J; Reigl T; van den Brand M; Kotrová M; Ritter JM; Catherwood MA; Stamatopoulos K; Brüggemann M; Davi F; Darzentas N; Pott C; Fend F; Hummel M; Langerak AW; Groenen PJTA;
Leukemia; 2019 Sep; 33(9):2227-2240. PubMed ID: 31197258
[TBL] [Abstract][Full Text] [Related]
9. Immune Gene Rearrangements: Unique Signatures for Tracing Physiological Lymphocytes and Leukemic Cells.
Kotrova M; Darzentas N; Pott C; Baldus CD; Brüggemann M
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34198966
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin/T-Cell Receptor Gene Rearrangement Analysis Using RNA-Seq.
van der Velden VHJ; Bastian L; Brüggemann M; Hartmann AM; Darzentas N
Methods Mol Biol; 2022; 2453():61-77. PubMed ID: 35622320
[TBL] [Abstract][Full Text] [Related]
11. Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in childhood acute lymphoblastic leukemia using a low-cost PCR strategy.
Assumpção JG; Ganazza MA; de Araújo M; Silva AS; Scrideli CA; Brandalise SR; Yunes JA
Pediatr Blood Cancer; 2010 Dec; 55(7):1278-86. PubMed ID: 20730889
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL.
Garand R; Beldjord K; Cavé H; Fossat C; Arnoux I; Asnafi V; Bertrand Y; Boulland ML; Brouzes C; Clappier E; Delabesse E; Fest T; Garnache-Ottou F; Huguet F; Jacob MC; Kuhlein E; Marty-Grès S; Plesa A; Robillard N; Roussel M; Tkaczuk J; Dombret H; Macintyre E; Ifrah N; Béné MC; Baruchel A
Leukemia; 2013 Feb; 27(2):370-6. PubMed ID: 23070018
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges.
Langerak AW; Brüggemann M; Davi F; Darzentas N; van Dongen JJM; Gonzalez D; Cazzaniga G; Giudicelli V; Lefranc MP; Giraud M; Macintyre EA; Hummel M; Pott C; Groenen PJTA; Stamatopoulos K;
J Immunol; 2017 May; 198(10):3765-3774. PubMed ID: 28416603
[TBL] [Abstract][Full Text] [Related]
14. MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR.
van der Velden VH; van Dongen JJ
Methods Mol Biol; 2009; 538():115-50. PubMed ID: 19277574
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia.
Mai H; Li Q; Wang G; Wang Y; Liu S; Tang X; Chen F; Zhou G; Liu Y; Li T; Wang L; Wang C; Wen F; Liu S
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3259-3266. PubMed ID: 35918464
[TBL] [Abstract][Full Text] [Related]
16. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
van Dongen JJ; Langerak AW; Brüggemann M; Evans PA; Hummel M; Lavender FL; Delabesse E; Davi F; Schuuring E; García-Sanz R; van Krieken JH; Droese J; González D; Bastard C; White HE; Spaargaren M; González M; Parreira A; Smith JL; Morgan GJ; Kneba M; Macintyre EA
Leukemia; 2003 Dec; 17(12):2257-317. PubMed ID: 14671650
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGS.
van den Brand M; Rijntjes J; Möbs M; Steinhilber J; van der Klift MY; Heezen KC; Kroeze LI; Reigl T; Porc J; Darzentas N; Luijks JACW; Scheijen B; Davi F; ElDaly H; Liu H; Anagnostopoulos I; Hummel M; Fend F; Langerak AW; Groenen PJTA;
J Mol Diagn; 2021 Sep; 23(9):1105-1115. PubMed ID: 34186174
[TBL] [Abstract][Full Text] [Related]
18. Quality Control for IG /TR Marker Identification and MRD Analysis.
Fronkova E; Svaton M; Trka J
Methods Mol Biol; 2022; 2453():91-99. PubMed ID: 35622322
[TBL] [Abstract][Full Text] [Related]
19. [Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in newly diagnosed adult patients with acute lymphoblastic leukemia by using multiplex PCR protocols].
Yao L; Chen ZX; Cen JN; Liang JY; He J; Qi XF; Shen HJ
Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):676-8. PubMed ID: 19176062
[TBL] [Abstract][Full Text] [Related]
20. [Gene rearrangement pattern of immunoglobulin and T-cell receptor (Ig/TR) and its clinical characteristics in children with SET-NUP214 fusion gene-positive leukemia/lymphoma].
Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xin YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1362-7. PubMed ID: 22169284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
